To confirm the presence of ANGPTL4 in podocytes in both healthy and diseased glomeruli, we conducted immunostaining with a commercial ANGPTL4 antibody on samples from 19 MCD, 5 FSGS, and 8 MN patients and 5 normal renal tissues. This evidence concerns the gene ANGPTL4 and focal segmental glomerulosclerosis.